Christopher G. Campbell is a Partner at DLA Piper and serves as Chair of the firm’s Product Liability and Mass Torts Group and Co-Chair of the Product Liability, Mass Torts & Class Actions Group. With more than 25 years of experience, Chris serves as global, national, and trial counsel in some of the most complex product liability, mass tort, and class action litigations worldwide. He has led coordinated defense strategies spanning five continents and more than a dozen countries, securing significant trial and appellate victories, including complete defense judgments in international class actions and high-profile multidistrict litigations.

Chris represents leading pharmaceutical, medical device, automotive, and consumer product manufacturers in regulatory-sensitive matters involving scientific, medical, and technical evidence. He is widely recognized for his ability to distill complex science into clear, persuasive courtroom narratives and for developing creative, unorthodox litigation strategies that position clients for early and decisive wins. In addition to active litigation, he advises companies on regulatory risk, pharmacovigilance, crisis management, privilege issues, and reputational strategy—helping align legal defense with broader business objectives.